Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.40
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

13 Jun 2012 10:25

RNS Number : 2670F
Flying Brands Limited
13 June 2012
 



13 June 2012

 

FLYING BRANDS LIMITED

 

RESULT OF ANNUAL GENERAL MEETING

 

The Board of Flying Brands Limited (the "Company") is pleased to announce that at the Company's Annual General Meeting held on Wednesday 13 June 2012 (the "AGM") the resolutions as set out in the Notice of AGM were duly passed on a show of hands.

 

The following levels of proxy appointments were received by the Company prior to the AGM:

 

Resolution

For

Against

Chairman's discretion (Note i)

Votes withheld

Number of shares

% of total

Number of shares

% of total

Number of shares

% of total

To receive and adopt the report and accounts

 

8,306,747

52.25

21,846

0.14

7,568,575

47.61

1,110,300

To approve the Remuneration Committee Report

 

9,345,865

55.05

62,652

0.37

7,569,070

44.58

29,881

To re-appoint John Henwood as a director

 

9,376,637

55.15

56,235

0.33

7,570,059

44.52

4,537

To re-appoint Paul Davidson as a director

 

9,376,521

55.15

55,951

0.33

7,570,059

44.52

4,937

To appoint Stuart Dootson as a director

 

9,408,751

55.34

24,121

0.14

7,570,059

44.52

4,537

To re-appoint Deloitte LLP as auditor and to authorise the directors to determine their remuneration

 

6,256,572

36.8

8,645

0.05

10,738,785

63.15

3,196

Special Resolution - To authorise the directors to make market purchases of ordinary shares

 

6,225,475

36.61

41,155

0.24

10,738,785

63.15

1,783

Special Resolution - To authorise the directors to allot ordinary shares without rights of pre-emption

4,153,661

24.43

2,112,606

12.42

10,738,785

63.15

2,146

 

Notes:

(i) Proxy appointments which gave discretion to the Chairman have been cast in favour of each resolution.

 

(ii) Issued share capital at 13 June 2012: 28,073,735 ordinary shares. Proxy appointments were received from shareholders holding the number of shares shown below, in each case representing the percentage of the issued share capital shown alongside:

 

Resolution 1

15,897,168 shares

56.63%

Resolution 2

16,977,587 shares

60.47%

Resolution 3

17,002,931 shares

60.56%

Resolution 4

17,002,531 shares

60.56%

Resolution 5

17,002,931 shares

60.56%

Resolution 6

17,004,272 shares

60.57%

Resolution 7

17,005,685 shares

60.57%

Resolution 8

17,005,322 shares

60.57%

 

 

(iii) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" the resolutions.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Group Finance Director

 

Smithfield Consultants 020 7360 4900

John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFJMLTMBTBMJT
Date   Source Headline
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial
2nd Sep 20217:00 amRNSBoard Changes
1st Sep 202110:00 amRNSStart of Trading on the OTCQB Venture Market
27th Aug 20219:57 amRNSHalf Yearly Report
11th Jun 20214:41 pmRNSSecond Price Monitoring Extn
11th Jun 20214:36 pmRNSPrice Monitoring Extension
11th Jun 20212:05 pmRNSSecond Price Monitoring Extn
11th Jun 20212:00 pmRNSPrice Monitoring Extension
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20218:00 amRNSIQAI Awarded “Gad-Free” Patent
4th Jun 20217:00 amRNSIB Software Chosen by LA County Hospital
19th May 202112:06 pmRNSResult of AGM
27th Apr 20213:27 pmRNSNotice of AGM
20th Apr 202110:21 amRNSFinal Results
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20217:27 amRNSIQAI commits to Phase 1 study
6th Apr 20217:00 amRNSFive Year NCI Award Grant to IB
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.